Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamide
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-11-01
|
| Series: | European Urology Open Science |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168324002817 |
| _version_ | 1797289697923301376 |
|---|---|
| author | J. Davis AHN Hahn GCM Manyam BFC Chapin MZ Zhang YY Yu CAP Pettaway LC Chery LLP Pisters JFW Ward JRG Gregg JP Papadopoulos ML Lozano AH Hoang BB Broom XW Wang CDH Huff CJL Logothetis PT Troncoso PGP Pilie |
| author_facet | J. Davis AHN Hahn GCM Manyam BFC Chapin MZ Zhang YY Yu CAP Pettaway LC Chery LLP Pisters JFW Ward JRG Gregg JP Papadopoulos ML Lozano AH Hoang BB Broom XW Wang CDH Huff CJL Logothetis PT Troncoso PGP Pilie |
| author_sort | J. Davis |
| collection | DOAJ |
| first_indexed | 2024-03-07T19:08:49Z |
| format | Article |
| id | doaj.art-d57ca367a18d44149297593afbeb81f0 |
| institution | Directory Open Access Journal |
| issn | 2666-1683 |
| language | English |
| last_indexed | 2024-03-07T19:08:49Z |
| publishDate | 2023-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | European Urology Open Science |
| spelling | doaj.art-d57ca367a18d44149297593afbeb81f02024-03-01T05:07:12ZengElsevierEuropean Urology Open Science2666-16832023-11-0160S7Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamideJ. DavisAHN HahnGCM ManyamBFC ChapinMZ ZhangYY YuCAP PettawayLC CheryLLP PistersJFW WardJRG GreggJP PapadopoulosML LozanoAH HoangBB BroomXW WangCDH HuffCJL LogothetisPT TroncosoPGP Piliehttp://www.sciencedirect.com/science/article/pii/S2666168324002817 |
| spellingShingle | J. Davis AHN Hahn GCM Manyam BFC Chapin MZ Zhang YY Yu CAP Pettaway LC Chery LLP Pisters JFW Ward JRG Gregg JP Papadopoulos ML Lozano AH Hoang BB Broom XW Wang CDH Huff CJL Logothetis PT Troncoso PGP Pilie Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamide European Urology Open Science |
| title | Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamide |
| title_full | Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamide |
| title_fullStr | Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamide |
| title_full_unstemmed | Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamide |
| title_short | Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamide |
| title_sort | molecular features of clinical outcomes in men with localized intermediate risk prostate cancer treated with pre operative apalutamide |
| url | http://www.sciencedirect.com/science/article/pii/S2666168324002817 |
| work_keys_str_mv | AT jdavis molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT ahnhahn molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT gcmmanyam molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT bfcchapin molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT mzzhang molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT yyyu molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT cappettaway molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT lcchery molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT llppisters molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT jfwward molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT jrggregg molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT jppapadopoulos molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT mllozano molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT ahhoang molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT bbbroom molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT xwwang molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT cdhhuff molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT cjllogothetis molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT pttroncoso molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide AT pgppilie molecularfeaturesofclinicaloutcomesinmenwithlocalizedintermediateriskprostatecancertreatedwithpreoperativeapalutamide |